Key facts
- It has raised $830K; the latest was Later Stage VC in Apr 2025.
- Notable investors include European Union, KFund, Shilling (Portugal), PharmStars, Armilar Venture Partners — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Promptly
- ·The full record, as it builds
Funding rounds
No funding rounds for Promptly are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Promptly
Developer of a digital healthcare technology designed to collect and analyze data on the outcomes of care. The company's technology helps to anticipate how one will feel before starting any treatment, track progress during treatment and offers information about the clinical conditions, symptoms, treatment, recovery and healthy living strategies validated by doctors, enabling patients to have a follow-up of the outcomes of their medical treatments.
- Sector
- Healthcare
- HQ
- Porto, Portugal
- Founded
- 2018
- Employees
- 66
- Website
- promptlyhealth.com/
- Ownership
- Privately Held (backing)
Promptly doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Promptly shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Promptly in its N-PORT filings yet. We sweep new filings monthly.